October 27, 2020false000020352700002035272020-10-272020-10-27

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 
 
Date of report (Date of earliest event reported) October 27, 2020
  
VARIAN MEDICAL SYSTEMS, INC.
(Exact Name of Registrant as Specified in its Charter)
  
Delaware 1-7598 94-2359345
(State or Other Jurisdiction
of Incorporation) 		(Commission File
Number) 		(IRS Employer
 Identification No.)
 
3100 Hansen Way, Palo Alto CA 94304-1030
(Address of Principal Executive Offices) (Zip Code)
 
Registrant's telephone number, including area code (650)  493-4000
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered:
Common Stock, $1 par value VAR New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 2.02. Results of Operations and Financial Condition.
 
On October 27, 2020, Varian Medical Systems, Inc. (the “Company”) issued a press release announcing its preliminary results of operations for the three and twelve months ended October 2, 2020. A copy of the press release is attached as Exhibit 99.1. A slide presentation, which includes supplemental information relating to the Company, is attached as Exhibit 99.2. The exhibits will be posted on the Company's website at www.varian.com under the "Investors" section.
The information furnished under Item 2.02 of this Current Report on Form 8-K, including the exhibits, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference into the Company’s filings with the SEC under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

A copy of the press release is attached as Exhibit 99.1.
 
Item 9.01. Financial Statements and Exhibits.
 
(i)Exhibits.
99.1
99.2
104 Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document.

 
2



SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 

  Varian Medical Systems, Inc.
     
     
  By: /s/ J. Michael Bruff
  Name:  J. Michael Bruff
  Title: Senior Vice President and Chief Financial Officer
  
Dated: October 27, 2020




3



Varian Medical System (NYSE:VAR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Varian Medical System Charts.
Varian Medical System (NYSE:VAR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Varian Medical System Charts.